Goldman Sachs’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.3M Sell
104,874
-132
-0.1% -$31.9K ﹤0.01% 1618
2025
Q1
$25.6M Buy
105,006
+32,874
+46% +$8.01M ﹤0.01% 1510
2024
Q4
$23.7M Sell
72,132
-5,635
-7% -$1.85M ﹤0.01% 1646
2024
Q3
$26M Sell
77,767
-57,160
-42% -$19.1M ﹤0.01% 1525
2024
Q2
$36.8M Buy
134,927
+79,157
+142% +$21.6M 0.01% 1170
2024
Q1
$19.3M Sell
55,770
-88,563
-61% -$30.6M ﹤0.01% 1570
2023
Q4
$46.6M Buy
144,333
+118,304
+455% +$38.2M 0.01% 1035
2023
Q3
$9.33M Sell
26,029
-15,770
-38% -$5.65M ﹤0.01% 2035
2023
Q2
$15.8M Buy
41,799
+7,650
+22% +$2.9M ﹤0.01% 1719
2023
Q1
$16.4M Buy
34,149
+9,960
+41% +$4.77M ﹤0.01% 1665
2022
Q4
$10.2M Sell
24,189
-21,560
-47% -$9.07M ﹤0.01% 2122
2022
Q3
$19.1M Buy
45,749
+14,234
+45% +$5.94M ﹤0.01% 1637
2022
Q2
$15.6M Sell
31,515
-50,030
-61% -$24.8M ﹤0.01% 1795
2022
Q1
$45.9M Buy
81,545
+1,144
+1% +$644K 0.01% 1141
2021
Q4
$60.7M Buy
80,401
+1,615
+2% +$1.22M 0.01% 1005
2021
Q3
$58.8M Buy
78,786
+15,747
+25% +$11.7M 0.01% 1000
2021
Q2
$40.6M Buy
63,039
+28,854
+84% +$18.6M 0.01% 1228
2021
Q1
$19.5M Sell
34,185
-5,146
-13% -$2.94M ﹤0.01% 1694
2020
Q4
$22.9M Buy
39,331
+15,466
+65% +$9.02M 0.01% 1463
2020
Q3
$12.3M Sell
23,865
-110,348
-82% -$56.9M ﹤0.01% 1809
2020
Q2
$60.6M Sell
134,213
-34,689
-21% -$15.7M 0.02% 735
2020
Q1
$59.2M Sell
168,902
-11,363
-6% -$3.98M 0.02% 687
2019
Q4
$66.7M Buy
180,265
+57,772
+47% +$21.4M 0.02% 855
2019
Q3
$40.8M Buy
122,493
+1,066
+0.9% +$355K 0.01% 1106
2019
Q2
$38M Sell
121,427
-50,413
-29% -$15.8M 0.01% 1192
2019
Q1
$52.5M Sell
171,840
-25,798
-13% -$7.89M 0.02% 974
2018
Q4
$45.9M Sell
197,638
-23,232
-11% -$5.39M 0.01% 1004
2018
Q3
$69.1M Buy
220,870
+5,906
+3% +$1.85M 0.02% 896
2018
Q2
$62M Buy
214,964
+107,550
+100% +$31M 0.02% 951
2018
Q1
$26.9M Sell
107,414
-35,740
-25% -$8.94M 0.01% 1391
2017
Q4
$34.2M Buy
143,154
+41,208
+40% +$9.84M 0.01% 1280
2017
Q3
$22.7M Sell
101,946
-4,339
-4% -$964K 0.01% 1509
2017
Q2
$24.1M Buy
106,285
+24,149
+29% +$5.47M 0.01% 1454
2017
Q1
$16.4M Buy
82,136
+1,482
+2% +$295K ﹤0.01% 1617
2016
Q4
$14.7M Buy
80,654
+15,261
+23% +$2.78M ﹤0.01% 1641
2016
Q3
$10.7M Sell
65,393
-9,083
-12% -$1.49M ﹤0.01% 1814
2016
Q2
$10.7M Sell
74,476
-36,077
-33% -$5.16M ﹤0.01% 1718
2016
Q1
$15.1M Buy
110,553
+29,932
+37% +$4.09M 0.01% 1519
2015
Q4
$11.2M Buy
80,621
+10,061
+14% +$1.39M ﹤0.01% 1627
2015
Q3
$9.48M Buy
70,560
+9,686
+16% +$1.3M ﹤0.01% 1655
2015
Q2
$9.17M Buy
60,874
+11,314
+23% +$1.7M ﹤0.01% 1732
2015
Q1
$6.7M Buy
49,560
+6,291
+15% +$850K ﹤0.01% 1871
2014
Q4
$5.22M Buy
43,269
+17,433
+67% +$2.1M ﹤0.01% 1963
2014
Q3
$2.93M Sell
25,836
-7,183
-22% -$815K ﹤0.01% 2295
2014
Q2
$3.95M Buy
33,019
+4,286
+15% +$513K ﹤0.01% 2142
2014
Q1
$3.68M Buy
28,733
+4,286
+18% +$549K ﹤0.01% 2203
2013
Q4
$3.02M Sell
24,447
-1,998
-8% -$247K ﹤0.01% 2346
2013
Q3
$3.11M Buy
26,445
+16,397
+163% +$1.93M ﹤0.01% 2224
2013
Q2
$1.13M Buy
+10,048
New +$1.13M ﹤0.01% 2729